Literature DB >> 28138599

The thinking to the huge disease burden of gastric cancer in China and the increasing tendency of esophagogastric junctional adenocarcinoma.

Kun Yang1, Jian-Kun Hu1.   

Abstract

Entities:  

Year:  2016        PMID： 28138599      PMCID： PMC5244769          DOI： 10.21037/tgh.2016.03.25

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  19 in total

1.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

2.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.

Authors:  J Lagergren; R Bergström; A Lindgren; O Nyrén
Journal:  N Engl J Med       Date:  1999-03-18       Impact factor: 91.245

3.  Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.

Authors:  Sung Hoon Noh; Sook Ryun Park; Han-Kwang Yang; Hyun Cheol Chung; Ik-Joo Chung; Sang-Woon Kim; Hyung-Ho Kim; Jin-Hyuk Choi; Hoon-Kyo Kim; Wansik Yu; Jong Inn Lee; Dong Bok Shin; Jiafu Ji; Jen-Shi Chen; Yunni Lim; Stella Ha; Yung-Jue Bang
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

Review 4.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Authors:  Nicholas Shaheen; David F Ransohoff
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

5.  Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium.

Authors:  Michael B Cook; Farin Kamangar; David C Whiteman; Neal D Freedman; Marilie D Gammon; Leslie Bernstein; Linda M Brown; Harvey A Risch; Weimin Ye; Linda Sharp; Nirmala Pandeya; Penelope M Webb; Anna H Wu; Mary H Ward; Carol Giffen; Alan G Casson; Christian C Abnet; Liam J Murray; Douglas A Corley; Olof Nyrén; Thomas L Vaughan; Wong-Ho Chow
Journal:  J Natl Cancer Inst       Date:  2010-08-17       Impact factor: 13.506

6.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.

Authors:  Shinichi Sakuramoto; Mitsuru Sasako; Toshiharu Yamaguchi; Taira Kinoshita; Masashi Fujii; Atsushi Nashimoto; Hiroshi Furukawa; Toshifusa Nakajima; Yasuo Ohashi; Hiroshi Imamura; Masayuki Higashino; Yoshitaka Yamamura; Akira Kurita; Kuniyoshi Arai
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

7.  Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry.

Authors:  Atsushi Nashimoto; Kohei Akazawa; Yoh Isobe; Isao Miyashiro; Hitoshi Katai; Yasuhiro Kodera; Shunichi Tsujitani; Yasuyuki Seto; Hiroshi Furukawa; Ichiro Oda; Hiroyuki Ono; Satoshi Tanabe; Michio Kaminishi
Journal:  Gastric Cancer       Date:  2012-06-23       Impact factor: 7.370

8.  Changes of Esophagogastric Junctional Adenocarcinoma and Gastroesophageal Reflux Disease Among Surgical Patients During 1988-2012: A Single-institution, High-volume Experience in China.

Authors:  Kai Liu; Kun Yang; Weihan Zhang; Xiaolong Chen; Xinzu Chen; Bo Zhang; Zhixin Chen; Jiaping Chen; Yongfan Zhao; Zongguang Zhou; Longqi Chen; Jiankun Hu
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

9.  Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model.

Authors:  Jennifer M Yeh; Chin Hur; Deb Schrag; Karen M Kuntz; Majid Ezzati; Natasha Stout; Zachary Ward; Sue J Goldie
Journal:  PLoS Med       Date:  2013-05-21       Impact factor: 11.069

10.  Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012.

Authors:  Kyu-Won Jung; Young-Joo Won; Hyun-Joo Kong; Chang-Mo Oh; Hyunsoon Cho; Duk Hyoung Lee; Kang Hyun Lee
Journal:  Cancer Res Treat       Date:  2015-03-03       Impact factor: 4.679
View more
  1 in total

1.  The esophagogastric junctional adenocarcinoma an increasing disease.

Authors:  Monica Pastina; Cecilia Menna; Claudio Andreetti; Mohsen Ibrahim
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.